Startseite Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report

  • Ji Hong Park ORCID logo , Ji Hyun Kim , Yo Han Ahn EMAIL logo , Hee Gyung Kang , Il Soo Ha und Hae Il Cheong
Veröffentlicht/Copyright: 6. September 2021

Abstract

Objectives: Gordon syndrome (GS), also known as pseudohypoaldosteronism type II, is a rare tubular disease characterized by hypertension, hyperkalemia, and metabolic acidosis. Its causative genes are CUL3, KLHL3, WNK1, and WNK4, and they are associated with varying severity of the disease. Herein, we report the first case of GS caused by a CUL3 mutation in a patient with short stature in Korea.Case presentation: A 7-year-old boy had hypertension, metabolic acidosis, and persistent hyperkalemia, which were initially detected during the evaluation of short stature. He was born small for gestational age at late preterm gestation. Laboratory test findings showed hyperkalemia with low trans-tubular potassium gradient, hyperchloremic metabolic acidosis with a normal anion gap, and low plasma renin levels. Genetic analysis revealed a heterozygous de novo mutation in the CUL3 gene (c.1377+1G > C in intron 9). Thus, a diagnosis of GS was made. The results of the endocrine function test (including growth hormone stimulation tests) were normal. After thiazide treatment, the patient’s electrolyte levels were normalized. However, he presented with persistent hypertension and short stature.Conclusions: GS should be considered in children with short stature, hypertension, and hyperkalemia, and early treatment may reduce complications.


Corresponding author: Yo Han Ahn, MD, PhD, Department of Pediatrics, Seoul National University Children’s Hospital & College of Medicine 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea; and Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea, Phone: +82 2 2072 3550, Fax: +82 2 2072 0633, E-mail:

Funding source: National Research Foundation of Korea 10.13039/501100003725

Award Identifier / Grant number: 2020R1A2C1100974

Acknowledgment

All authors thank the patient and parents for their participation in this study.

  1. Research funding: This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1A2C1100974).

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

References

1. O’Shaughnessy, KM. Gordon Syndrome: a continuing story. Pediatr Nephrol 2015;30:1903–8. https://doi.org/10.1007/s00467-014-2956-7.Suche in Google Scholar PubMed

2. Boyden, LM, Choi, M, Choate, KA, Nelson-Williams, CJ, Farhi, A, Toka, HR, et al.. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 2012;482:98–102. https://doi.org/10.1038/nature10814.Suche in Google Scholar PubMed PubMed Central

3. Alessi, DR, Zhang, J, Khanna, A, Hochdorfer, T, Shang, Y, Kahle, KT. The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters. Sci Signal 2014;7:re3. https://doi.org/10.1126/scisignal.2005365.Suche in Google Scholar PubMed

4. Park, JS, Park, E, Hyun, HS, Ahn, YH, Kang, HG, Ha, I-S, et al.. Three cases of Gordon syndrome with dominant KLHL3 mutations. J Pediatr Endocrinol Metab 2017;30:361–4. https://doi.org/10.1515/jpem-2016-0309.Suche in Google Scholar PubMed

5. Glover, M, Ware, JS, Henry, A, Wolley, M, Walsh, R, Wain, LV, et al.. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon’s syndrome). Clin Sci (Lond) 2014;126:721–6. https://doi.org/10.1042/cs20130326.Suche in Google Scholar

6. Osawa, M, Ogura, Y, Isobe, K, Uchida, S, Nonoyama, S, Kawaguchi, H. CUL3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancy. Pediatr Nephrol 2013;28:1881–4. https://doi.org/10.1007/s00467-013-2496-6.Suche in Google Scholar PubMed

7. Abdel Khalek, W, Rafael, C, Loisel-Ferreira, I, Kouranti, I, Clauser, E, Hadchouel, J, et al.. Severe arterial hypertension from Cullin 3 mutations is caused by both renal and vascular effects. J Am Soc Nephrol 2019;30:811–23. https://doi.org/10.1681/asn.2017121307.Suche in Google Scholar PubMed PubMed Central

8. Agbor, LN, Ibeawuchi, SC, Hu, C, Wu, J, Davis, DR, Keen, HL, et al.. Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism. JCI Insight 2016;1: e91015. https://doi.org/10.1172/jci.insight.91015.Suche in Google Scholar PubMed PubMed Central

9. Yavas Abali, Z, Yesil, G, Kirkgoz, T, Cicek, N, Alpay, H, Turan, S, et al.. Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers. Pediatr Nephrol 2020;35:405–7. https://doi.org/10.1007/s00467-019-04352-1.Suche in Google Scholar PubMed

10. Green, J, Maor, G. Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers. Kidney Int 2000;57:2258–67. https://doi.org/10.1046/j.1523-1755.2000.00086.x.Suche in Google Scholar PubMed

Received: 2021-06-01
Accepted: 2021-08-20
Published Online: 2021-09-06
Published in Print: 2022-02-23

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Obesity after the Covid-19 pandemic and beyond
  4. Review Article
  5. Clinical profile and management challenges of disorders of sex development in Africa: a systematic review
  6. Original Articles
  7. Development and validation of a mobile application for point of care evaluation of growth failure
  8. Children-Dietary Inflammatory Index (C-DII), cardiometabolic risk, and inflammation in adolescents: a cross-sectional study
  9. Accelerated pubertal onset in short children with delayed bone age
  10. Screening for hypophosphatasia: does biochemistry lead the way?
  11. Subcutaneous regular insulin use for the management of diabetic ketoacidosis in resource limited setting
  12. NPR2 gene variants in familial short stature: a single-center study
  13. The effect of the COVID-19 pandemic on metabolic control in children with type 1 diabetes: a single-center experience
  14. Evaluating a standardized protocol for the management of diabetes insipidus in pediatric neurosurgical patients
  15. Development and assessment of a low-health-literacy, pictographic adrenal insufficiency action plan
  16. Effect of insulin resistance on lung function in asthmatic children
  17. A major health problem facing immigrant children: nutritional rickets
  18. Clinical profile, etiology, and diagnostic challenges of primary adrenal insufficiency in Sudanese children: 14-years’ experience from a resource limited setting
  19. Non-inferiority of liquid thyroxine in comparison to tablets formulation in the treatment of children with congenital hypothyroidism
  20. Short Communication
  21. Increased frequency of idiopathic central precocious puberty in girls during the COVID-19 pandemic: preliminary results of a tertiary center study
  22. Case Reports
  23. Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report
  24. Nitisinone treatment during two pregnancies and breastfeeding in a woman with tyrosinemia type 1 – a case report
  25. Myxedema crisis and ovarian hyperstimulation in a child with Down syndrome
  26. First successful concomitant therapy of immune tolerance induction therapy and desensitization in a CRIM-negative infantile Pompe patient
Heruntergeladen am 23.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0361/html
Button zum nach oben scrollen